CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo.
Meng W, Wang J, Wang B, Liu F, Li M, Zhao Y, Zhang C, Li Q, Chen J, Zhang L, Tang Y, Ma J.
Meng W, et al.
Cancer Manag Res. 2018 Nov 15;10:5747-5758. doi: 10.2147/CMAR.S183696. eCollection 2018.
Cancer Manag Res. 2018.
PMID: 30532595
Free PMC article.